MASH Diagnostics: Advances, Limitations, and the Path Ahead (Session 1)

Nov 10 2025
Convention Center: Ballroom A, Level 3
8:00 AM - 9:30 AM

World Class Speakers

Mazen Noureddin
Abstract Presenter

Mazen Noureddin

Houston Research Institute and Houston Methodist Hospital
Naim Alkhouri, MD, FAASLD
Abstract Presenter

Naim Alkhouri, MD, FAASLD

Summit Clinical Research
Heather Patton, MD, FAASLD
Moderator

Heather Patton, MD, FAASLD

VA San Diego Healthcare
Mark Muthiah, MBBS, FRCP (Edin.), FAMS, MMed, PhD
Moderator

Mark Muthiah, MBBS, FRCP (Edin.), FAMS, MMed, PhD

National University Hospital, Singapore

Description

Abstract Parallel sessions feature oral presentations from the authors of highly-rated abstracts submitted for presentation at The Liver Meeting.

Journey Maps

Presentations

8:30 AM - 8:45 AM
Apr 29 2026
Washington, D.C.

Distinguishing MASLD and MetALD/ALD Using Phosphatidylethanol and Non-Invasive Tests: A Multicenter Cohort Analysis

Mazen Noureddin , Abstract Presenter
MASLD
9:00 AM - 9:15 AM
Apr 29 2026
Washington, D.C.

Utility of FIB-4, Agile 4, and Platelet Count to Rule Out Cirrhosis on Biopsy in Patients with LSM Between 15-25 kPa: A Multi-Center Cohort Study

Naim Alkhouri, MD, FAASLD , Abstract Presenter
MASLD

Objectives

  • Review recent advancements in noninvasive diagnostic tools and biomarkers for MASH, including their clinical utility and validation status.
  • Discuss limitations, uncertainties, and practical challenges in implementing MASH diagnostics in clinical and research settings.